Healthcare Infection Control Practices Advisory Committee, (HICPAC), 55567 [E9-25913]
Download as PDF
Federal Register / Vol. 74, No. 207 / Wednesday, October 28, 2009 / Notices
52968. The time, place, and public
comment period of the ACD, CDC—HDS
meeting has changed. The meeting will
also be teleconferenced.
Time: 2 p.m.–3:30 p.m.
Place: CDC, 1600 Clifton Road, NE.,
Atlanta, GA 30333, Building 19, Room 247/
248, Global Communication Center. To
participate by teleconference, please dial 1–
800–369–2112 and enter passcode 4102105.
Status: Open to the public; teleconference
access limited only by availability of
telephone ports. The public is welcome to
participate during the public comments
period which is tentatively scheduled from 3
to 3:15 p.m. EDT.
Contact Person for More Information:
Walter W. Williams, M.D., M.P.H.,
Designated Federal Officer, ACD, CDC—HDS,
1600 Clifton Road, NE., M/S E67, Atlanta,
Georgia 30333. Telephone 404–498–2310, Email: www1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 22, 2009.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–26054 Filed 10–27–09; 8:45 am]
55567
Agenda: To review and evaluate grant
applications.
Place: Nat’l Institute of Environmental
Health Sciences, 530 Davis Drive,
Morrisville, NC 27560 (Telephone
Conference Call).
Contact Person: Teresa Nesbitt, PhD, DVM,
Chief, Scientific Review Branch, Division of
Extramural Research and Training, Nat’l
Institute of Environmental Health Sciences,
P.O. Box 12233, MD EC–30, Research
Triangle Park, NC 27709, (919) 541–7571,
nesbittt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Matters To Be Discussed: The agenda will
include updates on Recovery Act activities
and the draft guideline for prevention of
intravascular catheter-related bloodstream
infections, and discussion of infection
control in ambulatory care settings.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Michelle King, HICPAC, Division of
Healthcare Quality Promotion, NCPDCID,
CDC, l600 Clifton Road, NE., Mailstop A–07,
Atlanta, Georgia 30333 Telephone (404) 639–
2936.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 20, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Dated: October 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–25995 Filed 10–27–09; 8:45 am]
[FR Doc. E9–25913 Filed 10–27–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES (HHS)
National Cancer Institute; Notice of
Closed Meeting
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Healthcare Infection Control Practices
Advisory Committee, (HICPAC)
National Institutes of Health
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
erowe on DSK5CLS3C1PROD with NOTICES
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Conference Grant Review
With An Environmental Health Focus.
Date: November 20, 2009.
Time: 1 p.m. to 3:30 p.m.
VerDate Nov<24>2008
15:34 Oct 27, 2009
Jkt 220001
Times and Dates: 9 a.m.–5 p.m., November
12, 2009. 9 a.m.–12 p.m., November 13, 2009.
Place: Washington Marriott at Metro
Center, Salons C–D, 775 12th Street, NW.,
Washington, DC 20005, Telephone: (202)
737–2200.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, HHS; the Assistant Secretary for
Health, HHS; the Director, CDC; and the
Director, National Center for Preparedness,
Detection, and Control of Infectious Diseases
(NCPDCID), regarding: (1) The practice of
hospital infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Special Emphasis Panel; Systems for
Biomarker Research and Development.
Date: November 23, 2009.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Suite 703, Room 7142,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7142, Bethesda,
MD 20892, 301–594–9582,
vollbert@mail.nih.gov.
E:\FR\FM\28OCN1.SGM
28OCN1
Agencies
[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Page 55567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25913]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee,
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates: 9 a.m.-5 p.m., November 12, 2009. 9 a.m.-12
p.m., November 13, 2009.
Place: Washington Marriott at Metro Center, Salons C-D, 775 12th
Street, NW., Washington, DC 20005, Telephone: (202) 737-2200.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, HHS; the Assistant Secretary for Health,
HHS; the Director, CDC; and the Director, National Center for
Preparedness, Detection, and Control of Infectious Diseases
(NCPDCID), regarding: (1) The practice of hospital infection
control; (2) strategies for surveillance, prevention, and control of
infections (e.g., nosocomial infections), antimicrobial resistance,
and related events in settings where healthcare is provided; and (3)
periodic updating of guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on
Recovery Act activities and the draft guideline for prevention of
intravascular catheter-related bloodstream infections, and
discussion of infection control in ambulatory care settings.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Michelle King, HICPAC,
Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton
Road, NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404)
639-2936.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: October 20, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-25913 Filed 10-27-09; 8:45 am]
BILLING CODE 4163-18-P